vs
Azenta, Inc.（AZTA）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是Azenta, Inc.的1.3倍（$188.3M vs $148.6M），BRC Group Holdings, Inc.净利率更高（47.9% vs -10.4%，领先58.3%），Azenta, Inc.同比增速更快（0.8% vs -21.9%），过去两年Azenta, Inc.的营收复合增速更高（4.4% vs -15.4%）
Azenta成立于1978年，总部位于美国马萨诸塞州切姆斯福德，是全球知名的生命科学服务提供商，核心业务覆盖基因组学、低温存储、自动化解决方案及信息学服务，为生命科学领域研究及产业客户提供专业技术支持。
AZTA vs RILY — 直观对比
营收规模更大
RILY
是对方的1.3倍
$148.6M
营收增速更快
AZTA
高出22.6%
-21.9%
净利率更高
RILY
高出58.3%
-10.4%
两年增速更快
AZTA
近两年复合增速
-15.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $148.6M | $188.3M |
| 净利润 | $-15.4M | $90.3M |
| 毛利率 | 42.9% | 79.5% |
| 营业利润率 | -4.9% | 32.3% |
| 净利率 | -10.4% | 47.9% |
| 营收同比 | 0.8% | -21.9% |
| 净利润同比 | -15.7% | 1710.8% |
| 每股收益（稀释后） | $-0.34 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AZTARILY
| Q4 25 | $148.6M | $188.3M | ||
| Q3 25 | $159.2M | $215.3M | ||
| Q2 25 | $143.9M | $188.2M | ||
| Q1 25 | $143.3M | $197.2M | ||
| Q4 24 | $147.4M | $241.0M | ||
| Q3 24 | $150.6M | $225.5M | ||
| Q2 24 | $144.3M | $256.0M | ||
| Q1 24 | $136.4M | $263.4M |
净利润AZTARILY
| Q4 25 | $-15.4M | $90.3M | ||
| Q3 25 | $50.9M | $91.1M | ||
| Q2 25 | $-48.0M | $139.5M | ||
| Q1 25 | $-47.7M | $-10.0M | ||
| Q4 24 | $-11.0M | $-5.6M | ||
| Q3 24 | $-6.6M | $-284.4M | ||
| Q2 24 | $-6.6M | $-433.6M | ||
| Q1 24 | $-137.4M | $-49.2M |
毛利率AZTARILY
| Q4 25 | 42.9% | 79.5% | ||
| Q3 25 | 45.4% | 83.7% | ||
| Q2 25 | 46.2% | 81.3% | ||
| Q1 25 | 43.8% | 81.4% | ||
| Q4 24 | 46.7% | 79.8% | ||
| Q3 24 | 45.5% | 82.1% | ||
| Q2 24 | 44.8% | 84.5% | ||
| Q1 24 | 43.8% | 85.3% |
营业利润率AZTARILY
| Q4 25 | -4.9% | 32.3% | ||
| Q3 25 | 1.2% | 30.4% | ||
| Q2 25 | -1.3% | 5.7% | ||
| Q1 25 | -12.7% | -31.2% | ||
| Q4 24 | -5.9% | -69.2% | ||
| Q3 24 | -3.1% | -36.4% | ||
| Q2 24 | -4.9% | -90.8% | ||
| Q1 24 | -18.1% | -6.1% |
净利率AZTARILY
| Q4 25 | -10.4% | 47.9% | ||
| Q3 25 | 32.0% | 42.3% | ||
| Q2 25 | -33.4% | 74.1% | ||
| Q1 25 | -33.3% | -5.1% | ||
| Q4 24 | -7.5% | -2.3% | ||
| Q3 24 | -4.4% | -126.1% | ||
| Q2 24 | -4.5% | -169.4% | ||
| Q1 24 | -100.8% | -18.7% |
每股收益（稀释后）AZTARILY
| Q4 25 | $-0.34 | $2.78 | ||
| Q3 25 | $1.12 | $2.91 | ||
| Q2 25 | $-1.05 | $4.50 | ||
| Q1 25 | $-1.04 | $-0.39 | ||
| Q4 24 | $-0.25 | $-0.01 | ||
| Q3 24 | $-0.25 | $-9.39 | ||
| Q2 24 | $-0.12 | $-14.35 | ||
| Q1 24 | $-2.48 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $336.6M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $1.7B | $-171.5M |
| 总资产 | $2.1B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AZTARILY
| Q4 25 | $336.6M | $226.6M | ||
| Q3 25 | $279.8M | $184.2M | ||
| Q2 25 | $270.0M | $267.4M | ||
| Q1 25 | $253.6M | $138.3M | ||
| Q4 24 | $377.5M | $146.9M | ||
| Q3 24 | $280.0M | $159.2M | ||
| Q2 24 | $336.5M | $236.9M | ||
| Q1 24 | $353.5M | $190.7M |
总债务AZTARILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AZTARILY
| Q4 25 | $1.7B | $-171.5M | ||
| Q3 25 | $1.7B | $-260.5M | ||
| Q2 25 | $1.7B | $-351.7M | ||
| Q1 25 | $1.7B | $-496.8M | ||
| Q4 24 | $1.7B | $-488.2M | ||
| Q3 24 | $1.8B | $-497.6M | ||
| Q2 24 | $2.0B | $-218.3M | ||
| Q1 24 | $2.2B | $228.4M |
总资产AZTARILY
| Q4 25 | $2.1B | $1.7B | ||
| Q3 25 | $2.1B | $1.7B | ||
| Q2 25 | $2.0B | $1.5B | ||
| Q1 25 | $2.0B | $1.5B | ||
| Q4 24 | $2.0B | $1.8B | ||
| Q3 24 | $2.1B | $2.2B | ||
| Q2 24 | $2.3B | $3.2B | ||
| Q1 24 | $2.6B | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.8M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $14.7M | — |
| 自由现金流率自由现金流/营收 | 9.9% | — |
| 资本支出强度资本支出/营收 | 4.2% | — |
| 现金转化率经营现金流/净利润 | — | 0.29× |
| 过去12个月自由现金流最近4个季度 | $30.9M | — |
8季度趋势，按日历期对齐
经营现金流AZTARILY
| Q4 25 | $20.8M | $26.2M | ||
| Q3 25 | $2.2M | $-60.6M | ||
| Q2 25 | $25.8M | $-25.6M | ||
| Q1 25 | $14.4M | $184.0K | ||
| Q4 24 | $29.8M | $-2.7M | ||
| Q3 24 | $17.7M | $19.5M | ||
| Q2 24 | $9.8M | $111.5M | ||
| Q1 24 | $8.7M | $135.4M |
自由现金流AZTARILY
| Q4 25 | $14.7M | — | ||
| Q3 25 | $-5.7M | — | ||
| Q2 25 | $15.0M | — | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $8.3M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $428.0K | — |
自由现金流率AZTARILY
| Q4 25 | 9.9% | — | ||
| Q3 25 | -3.6% | — | ||
| Q2 25 | 10.4% | — | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | 15.0% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 0.3% | — |
资本支出强度AZTARILY
| Q4 25 | 4.2% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 5.2% | — | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 6.1% | — |
现金转化率AZTARILY
| Q4 25 | — | 0.29× | ||
| Q3 25 | 0.04× | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
